Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

RecruitingOBSERVATIONAL
Enrollment

1,174

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Pancreatic CancerPancreatic Cyst
Interventions
OTHER

Blood Sample collection

Participants will be asked to donate blood at baseline (+/- 30 days of diagnosis date), 4-6 weeks post-surgery, if applicable, and at the time of follow-up (approximately 1 year and approximately 2 years after baseline).

OTHER

Tissue sample collection

At the time of tissue biopsy and surgical resection (if applicable), pancreatic tumor tissue, muscle, fat, tissue from site of metastasis, and cyst fluid (if applicable) will be collected.

OTHER

Data collection

Participants will be asked to complete questionnaires at baseline and at 1 year and 2 year follow-ups.

Trial Locations (3)

33136

RECRUITING

Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital, Miami

33612

RECRUITING

Moffitt Cancer Center, Tampa

34211

RECRUITING

Florida Research Institute (FRI), Lakewood Rch

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Florida

OTHER

collaborator

University of Miami

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER